These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34059716)

  • 1. Freeze-thaw characterization process to minimize aggregation and enable drug product manufacturing of protein based therapeutics.
    Jain K; Salamat-Miller N; Taylor K
    Sci Rep; 2021 May; 11(1):11332. PubMed ID: 34059716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Freeze/Thaw Process on Drug Substance Storage of Therapeutics.
    Rayfield WJ; Kandula S; Khan H; Tugcu N
    J Pharm Sci; 2017 Aug; 106(8):1944-1951. PubMed ID: 28343990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fundamentals of freeze-drying.
    Nail SL; Jiang S; Chongprasert S; Knopp SA
    Pharm Biotechnol; 2002; 14():281-360. PubMed ID: 12189727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Buffer, Protein Concentration and Sucrose Addition on the Aggregation and Particle Formation during Freezing and Thawing.
    Hauptmann A; Podgoršek K; Kuzman D; Srčič S; Hoelzl G; Loerting T
    Pharm Res; 2018 Mar; 35(5):101. PubMed ID: 29556730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Freezing-induced perturbation of tertiary structure of a monoclonal antibody.
    Liu L; Braun LJ; Wang W; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Jul; 103(7):1979-1986. PubMed ID: 24832730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freeze thaw and lyophilization induced alteration in mAb therapeutics: Trastuzumab as a case study.
    Dash R; Rathore AS
    J Pharm Biomed Anal; 2021 Jul; 201():114122. PubMed ID: 33989996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freeze/thaw of IGG solutions.
    Horn J; Jena S; Aksan A; Friess W
    Eur J Pharm Biopharm; 2019 Jan; 134():185-189. PubMed ID: 30529434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine.
    Agarwal S; Sahni N; Hickey JM; Robertson GA; Sitrin R; Cryz S; Joshi SB; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):394-406. PubMed ID: 31400346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Propylene Glycol-Mitigated Freeze/Thaw Agglomeration of a Frozen Liquid nOMV Vaccine Formulation by Static Light Scattering and Micro-Flow Imaging.
    Mensch CD; Davis HB; Blue JT
    PDA J Pharm Sci Technol; 2015; 69(4):477-98. PubMed ID: 26242785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of experiments reveals critical parameters for pilot-scale freeze-and-thaw processing of L-lactic dehydrogenase.
    Roessl U; Humi S; Leitgeb S; Nidetzky B
    Biotechnol J; 2015 Sep; 10(9):1390-9. PubMed ID: 25820483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Multiple Freeze-Thaw Cycles on Biochemical and Physical Quality Changes of White Shrimp (Penaeus vannamei) Treated with Lysine and Sodium Bicarbonate.
    Wachirasiri K; Wanlapa S; Uttapap D; Puttanlek C; Rungsardthong V
    J Food Sci; 2019 Jul; 84(7):1784-1790. PubMed ID: 31218686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Uncontrolled vs Controlled Rate Freeze-Thaw Technologies on Process Performance and Product Quality.
    Padala C; Jameel F; Rathore N; Gupta K; Sethuraman A
    PDA J Pharm Sci Technol; 2010; 64(4):290-8. PubMed ID: 21502029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of solution conditions, processing parameters, and container materials on aggregation of a monoclonal antibody during freeze-thawing.
    Kueltzo LA; Wang W; Randolph TW; Carpenter JF
    J Pharm Sci; 2008 May; 97(5):1801-12. PubMed ID: 17823949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of mAb Aggregation on Its Biological Activity: Rituximab as a Case Study.
    Bansal R; Dash R; Rathore AS
    J Pharm Sci; 2020 Sep; 109(9):2684-2698. PubMed ID: 32473898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interest of flow injection spectrophotometry as an orthogonal method for analyzing biomolecule aggregates: Application to stressed monoclonal antibody study.
    Jaccoulet E; Daniel T; Dammak D; Prognon P; Caudron E
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Apr; 251():119436. PubMed ID: 33461132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Scale Freeze-Thaw of Protein Solutions: Study of the Relative Contributions of Freeze-Concentration and Ice Surface Area on Stability of Lactate Dehydrogenase.
    Minatovicz B; Sansare S; Mehta T; Bogner RH; Chaudhuri B
    J Pharm Sci; 2023 Feb; 112(2):482-491. PubMed ID: 36162492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new scaleable freeze-thaw technology for bulk protein solutions.
    Shamlou PA; Breen LH; Bell WV; Pollo M; Thomas BA
    Biotechnol Appl Biochem; 2007 Jan; 46(Pt 1):13-26. PubMed ID: 16903838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperature Based Process Characterization of Pharmaceutical Freeze-Thaw Operations.
    Weber D; Hubbuch J
    Front Bioeng Biotechnol; 2021; 9():617770. PubMed ID: 33898399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregates in monoclonal antibody manufacturing processes.
    Vázquez-Rey M; Lang DA
    Biotechnol Bioeng; 2011 Jul; 108(7):1494-508. PubMed ID: 21480193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the freezing of biopharmaceuticals: first-principle modeling of the process and evaluation of its effect on product quality.
    Radmanovic N; Serno T; Joerg S; Germershaus O
    J Pharm Sci; 2013 Aug; 102(8):2495-507. PubMed ID: 23775776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.